Supporting the boldest research ideas in the interdisciplinary labs under the direction of Robert H. Brown Jr., DPhil, MD, one of the world's foremost authorities on ALS.

Boston Marathon 2022

This year's event will take place on Monday, April 18, and the UMass ALS Cellucci Fund team will once again have five runners!

SPONSOR the Boston Marathon 2022 Cellucci Fund Team

Your organization can provide hope to those affected by ALS with something very rare and very needed: HOPE. Your organization can sponsor this year's team in their fundraising efforts.

UMass ALS Cellucci Fund 10-year 435w.jpg

A decade of dedication and discovery

UMass ALS Cellucci Fund marks 10-year milestone

May 2021 marked 10 years of steadfast and generous philanthropic support, as well as notable advances in ALS research being conducted at UMass Chan Medical School by Robert H. Brown Jr., DPhil, MD, and his colleagues.

Silencing of an ALS gene safely delivered to patients in UMass Medical School study

Synthetic microRNA treatment targets mutant SOD1 gene that causes ALS

UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.

Page Menu